Literature DB >> 8625964

Expression of high- and low-affinity receptors for C3a on the human mast cell line, HMC-1.

D F Legler1, M Loetscher, S A Jones, C A Dahinden, M Arock, B Moser.   

Abstract

The proteolytic cleavage product of complement component 3, (C3a), is like C4a and C5a, is a potent anaphylatoxin and induces the production of inflammatory mediators in phagocytes. Notably, mast cells respond to C3a with the release of vasoactive substances, including histamine. We have examined the function and receptor binding of C3a in a human leukemic mast cell line, HMC-1. Similar to chemoattractant agonists in leukocytes, C3a induced rapid cytosolic free calcium concentration increases in HMC-1 cells. EGTA did not diminish this response, indicating that mobilizable Ca2+ was from intracellular stores. Receptors of C3a in HMC-1 cells couple in part to Bordetella pertussis toxin-sensitive G-proteins and, therefore, appear to belong to the family of serpentine receptors that require G-proteins for signal transduction. HMC-1 cells express two types of C3a receptors, C3aR1 and C3aR2, that were shown to bind 125I-C3a with high-(Kd1 = 2.1-4.8 nM) or low-affinity (Kd2 = 30-150 nM), and both receptors are expressed at high level: 3 x 10(5)-6 x 10(5) C3aR1/cell and 5 x 10(5)-2.3 x 10(6) C3aR2/cell. Results from cross-linking experiments with 125I-C3a fully agree with the presence of two different classes of C3a receptors in HMC-1 cells. Two membrane proteins with apparent molecular masses of 54-61 kDa (p57) and 86-107 kDa (p97) could be covalently modified with 125I-C3a, and this cross-linking was inhibited with an excess of unlabeled C3a. Many of the known agonists for leukocytes including 13 chemokines (IL-8, NAP-2, GRO alpha, ENA-78, IP10, PF4, MCP-1, 2 and 3, RANTES, MIP-1 alpha, MIP-1 beta and I309), three neuropeptides (neuropeptide Y, somatostatin and calcitonin), as well as C5a, did not activate HMC-1 cells, indicating that C3a is one of a few protein ligands for which this cell line expresses specific receptors. The apparent selectivity for C3a and the abundant expression of C3a receptors make the HMC-1 cell line an excellent choice for the cloning of the receptor genes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8625964     DOI: 10.1002/eji.1830260405

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  10 in total

1.  Mast cell anaphylatoxin receptor expression can enhance IgE-dependent skin inflammation in mice.

Authors:  Beatrix Schäfer; Adrian M Piliponsky; Tatsuya Oka; Chang Ho Song; Norma P Gerard; Craig Gerard; Mindy Tsai; Janet Kalesnikoff; Stephen J Galli
Journal:  J Allergy Clin Immunol       Date:  2012-06-22       Impact factor: 10.793

2.  The receptor for the complement C3a anaphylatoxin (C3aR) provides host protection against Listeria monocytogenes-induced apoptosis.

Authors:  Stacey L Mueller-Ortiz; John E Morales; Rick A Wetsel
Journal:  J Immunol       Date:  2014-06-30       Impact factor: 5.422

3.  Evaluation of C3a receptor expression on human leucocytes by the use of novel monoclonal antibodies.

Authors:  J Zwirner; O Götze; G Begemann; A Kapp; K Kirchhoff; T Werfel
Journal:  Immunology       Date:  1999-05       Impact factor: 7.397

4.  Acylation-stimulating protein (ASP): structure-function determinants of cell surface binding and triacylglycerol synthetic activity.

Authors:  I Murray; J Köhl; K Cianflone
Journal:  Biochem J       Date:  1999-08-15       Impact factor: 3.857

5.  The anaphylatoxin C3a downregulates the Th2 response to epicutaneously introduced antigen.

Authors:  Seiji Kawamoto; Ali Yalcindag; Dhafer Laouini; Scott Brodeur; Paul Bryce; Bao Lu; Alison A Humbles; Hans Oettgen; Craig Gerard; Raif S Geha
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

6.  Functional and phenotypic studies of two variants of a human mast cell line with a distinct set of mutations in the c-kit proto-oncogene.

Authors:  Magnus Sundström; Harissios Vliagoftis; Peter Karlberg; Joseph H Butterfield; Kenneth Nilsson; Dean D Metcalfe; Gunnar Nilsson
Journal:  Immunology       Date:  2003-01       Impact factor: 7.397

7.  Requirements for membrane attack complex formation and anaphylatoxins binding to collagen-activated platelets.

Authors:  Catherine Martel; Sylvie Cointe; Pascal Maurice; Saïd Matar; Marta Ghitescu; Pierre Théroux; Arnaud Bonnefoy
Journal:  PLoS One       Date:  2011-04-15       Impact factor: 3.240

8.  The human C3a receptor is expressed on neutrophils and monocytes, but not on B or T lymphocytes.

Authors:  U Martin; D Bock; L Arseniev; M A Tornetta; R S Ames; W Bautsch; J Köhl; A Ganser; A Klos
Journal:  J Exp Med       Date:  1997-07-21       Impact factor: 14.307

9.  The C3aR promotes macrophage infiltration and regulates ANCA production but does not affect glomerular injury in experimental anti-myeloperoxidase glomerulonephritis.

Authors:  Jonathan Dick; Poh-Yi Gan; A Richard Kitching; Stephen R Holdsworth
Journal:  PLoS One       Date:  2018-01-09       Impact factor: 3.240

10.  Anaphylatoxins Activate Ca2+, Akt/PI3-Kinase, and FOXO1/FoxP3 in the Retinal Pigment Epithelium.

Authors:  Catharina Busch; Balasubramaniam Annamalai; Khava Abdusalamova; Nadine Reichhart; Christian Huber; Yuchen Lin; Emeraldo A H Jo; Peter F Zipfel; Christine Skerka; Gerhild Wildner; Maria Diedrichs-Möhring; Bärbel Rohrer; Olaf Strauß
Journal:  Front Immunol       Date:  2017-06-15       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.